Market Overview

Goldman Sachs Raises PT on CME Group to $270

Goldman Sachs has raised the price target on CME Group (NYSE: CME) from $250 to $270 and maintains its Neutral rating.

Posted-In: Goldman SachsPrice Target Pre-Market Outlook Analyst Ratings


Most Popular

Related Articles (CME)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional